Table 2.
Biological effects | Type of exosomes | Mechanism | References |
---|---|---|---|
Immunomodulatory effects | DPSCs-Exos |
Inhibit differentiation of CD4 + T cells into Th17 Reduce secretion of pro-inflammatory factors IL-17, TNF-α Promote polarization of CD4 + T cells into Treg cells Increase release of anti-inflammatory factors IL-10, TGF-β |
[39, 40, 43] |
SHEDs-Exos |
Suppress the expression of IL-6, IL-8, MMP1, MMP3, MMP9, MMP13, and ADAMTS5 SHEDs-Exo-enriched miR-100 suppresses inflammation via repression of mammalian target of rapamycin Suppressed carrageenan-induced acute inflammation in mice and suppressed the activities of cathepsin B and MMPs at the site of acute inflammation Low doses of exosomes inhibited the expression of the inflammatory cytokines IL-6 and TNF-α |
||
Osteogenesis effects | SCAPs-Exos | Enriched osteogenesis promoted pi-RNAs target to MAPK pathway | [41–45] |
SHEDs-Exos |
High ALP activity and upregulated osteogenic gene expression, including: RUNX2, OPN and OCN Contained the mRNA and proteins of Wnt3a and BMP2 activated BMP/Smad and Wnt/β-catenin signaling pathways Inhibit the apoptosis of BMSCs, promote the RUNX2 and p-Smad5 expression Inhibited adipogenesis |
||
GMSCs-Exos |
Promote the expression of osteogenic markers: RUNX2, VEGFA OPN and COL1A1 Combine the exosomes with the biomaterials promoted the formation of new bone spicules and blood vessels in the rat model |
||
Odontogenic effects | DPSCs-Exos |
Upregulation of DSP, DMP-1, ALP, and RUNX2, downregulation of latent TGF-β-binding protein 1 Promoted odontogenic differentiation via the TGFβ1/Smad signaling pathway Triggered the P38/MAPK pathway and promoted the expression of the genes required for odontogenic differentiation, including DMP1 and DPP Modulate Schwann Cells migration and odontogenic differentiation Attenuated the LPS-induced cell apoptosis of odontoblast-like cells |
[33, 46, 47, 49, 50] |
SCAPs-Exos |
Increased the gene expression of the dentinogenic marker DSP Promoted BMMSCs-based dentine-pulp complex regeneration |
||
Neuroprotection and nerve regeneration | DPSCs-Exos |
Protected neurons against excitotoxicity in vitro via the activation of endogenous cell survival mechanisms Upregulate the host's endogenous growth factor expression and prevent apoptosis via activation of the cell survival PI3K-B-cell lymphoma-2 pathway |
[32, 37, 52–56] |
SHEDs-Exos |
Suppressed 6-OHDA-induced gait impairments and slowed the number of 6-OHDA-induced contralateral rotations Significantly inhibited the secretion of TNF-α and IL-6 Reduce neuroinflammation by shifting microglia M1/M2 polarization |
||
GMSCs-Exos |
Promoted Schwann cell proliferation, migration and dorsal root ganglion axon growth Increase in the expression of Notch1, c-JUN, GFAP, and SOX2 Combined with the biomaterials effectively promoted tongue taste bud regeneration and peripheral nerve regeneration |
||
Wound healing and skin regeneration | GMSCs-Exos |
Promote the re-epithelialization, deposition and remodeling of collagen and the enhancing of angiogenesis and neuronal ingrowth in the wound area Contain higher amounts of IL-1RA |
[57, 58] |
Angiogenic effects | GMSCs-Exos | Contain exosomal miR-210 and promoted the expression of VEGF | [45, 59, 60] |
DPSCs-Exos |
HIF-1 enhanced exosomes secretion and increased the packaging of Jagged1 The addition of Jagged1-containing exosomes cultures to endothelial cells triggered transcriptional changes in Notch target genes and induced angiogenesis |
||
Antitumor effects | GMSCs-Exos |
PTX was incorporated into GMSCs-Exos during their biogenesis Exosomes with PTX produced a significant dose-dependent inhibition of squamous cancer cell growth |
[35, 62, 64] |
DPSCs-Exos |
After the transduction of DPSCs with the yCD::UPRT gene via retrovirus infection, the suicide gene yCD::UPRT mRNA was packed into the exosomes cargo The exosomes were internalized via recipient tumor cells and effectively triggered dose-dependent tumor cell death in the presence of the prodrug 5-fluorocytosine |